🇺🇸 FDA
Patent

US 7708987

Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

granted A61KA61K35/765A61K38/13

Quick answer

US patent 7708987 (Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders) held by ONCOLYTICS BIOTECH INC. expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ONCOLYTICS BIOTECH INC.
Grant date
Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K35/765, A61K38/13, A61P, A61P1/00